Omeros Corp. (OMER)
12.35
+0.34
(+2.83%)
USD |
NASDAQ |
Jan 20, 14:50
Omeros EPS Diluted (Quarterly): -0.4666 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Edgewise Therapeutics, Inc. | -0.3855 |
| GeoVax Labs, Inc. | -7.787 |
| Vistagen Therapeutics, Inc. | -0.5432 |
| Daré Bioscience, Inc. | -0.2793 |
| Spero Therapeutics, Inc. | -0.1312 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.24M |
| Total Expenses (Quarterly) | 21.24M |
| Enterprise Value | 1.179B |
| Earnings Yield | -16.34% |
| Normalized Earnings Yield | -16.09 |